Introduction
Staphylococcus aureus is well recognized as an invasive pathogen capable of causing such devastating diseases as endocarditis, shock, or metastatic suppurative collections (1) (2) . The morbidity and mortality of endovascular staphylococcal infections remains significant despite the availability of effective antimicrobial agents (1) (2) (3) (4) . The basis for this invasive potential is not clearly understood. One important pathogenetic mechanism that has received limited attention is the ability ofstaphylococci to colonize host tissue surfaces. Several studies have demonstrated the capacity ofS. aureus to adhere to connective tissue glycoproteins such as fibronectin, collagen, and laminin. These components have been recognized as potentially important receptors for bacterial adhesion in the presence of tis-sue injury (5) (6) (7) (8) . However, in the absence ofantecedent injury, as is often the case in acute infective endocarditis or staphylococcal bacteremia, the initial adhesion interaction is with the endothelial cell surface (3, 9) . Staphylococci are capable of adhering to and penetrating endothelial cells in greater numbers than other bacterial species (10) (11) (12) (13) (14) (15) . This affinity for endothelial cell tissue may be a consequence of adhesin-receptor interactions that occur between the bacteria and the endothelial cell surface (10, 12, 15) .
We have developed a procedure for the identification and isolation of endothelial cell surface components that bind S. aureus. This approach involves the adherence of staphylococci to detergent-solubilized, 2-iminobiotin-labeled endothelial cell membranes and their subsequent purification by streptavidin agarose affinity chromatography. In the present study, we describe the isolation of a 50-kD endothelial cell membrane component which binds and facilitates S. aureus attachment to endothelial cells, in vitro.
Methods

Endothelial cell tissue culture conditions
Human endothelial cells were harvested from umbilical veins and maintained in tissue culture as previously described ( 12, 16) . The culture media contained Medium 199 (M 199, Gibco Laboratories, Grand Island, NY), supplemented with 15 mM hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes; Calbiochem-Behring, La Jolla, CA), 25 ,Ag/ml of heparin (Sigma Chemical Co., St. Louis, MO), 10% human and 20% newborn calf serum (Gibco), 1.5 mM glutamine (Sigma), and 3 mg/ 100 ml partially purified acidic fibroblast growth factor extracted from bovine brain (16) . The cells were maintained at 37'C and 5 
Bacterial storage and preparation
The primary staphylococcal strain (Wb) used in these studies was a blood culture isolate from a patient with acute infective endocarditis. Other strains used were also blood culture isolates from clinically documented infections. Bacteria were stored and prepared for use as previously described (12) . Before a study, the bacteria were resuspended in M 199 containing 15 Biotinylation of endothelial cell membrane proteins. The solubilized membrane proteins were biotinylated with 50 mM Biotin-N-hydroxy-succinimide ester (NHS),' (Calbiochem-Berhing Diagnostics) in dimethysulfoxide. The proteins were incubated with biotin-NHS (final concentration 5 mM) for 2 h on ice. The excess biotin was removed by membrane dialysis (18) .
Identification of biotinylated endothelial cell membrane proteins which bind S. aureus. The staphylococcal strain (Wb) was adjusted to a density of I09 CFU/ml in M199, pH 7.4 containing 15 mM Hepes, I M NaCl, 0.1% bovine serum albumin (BSA), 1 mM PMSF, 1 mM iodoacetamide, 1 mM EDTA, and 10 mM benzamidine. Biotinylated membranes were incubated with bacteria for 2 h on ice. The suspension was centrifuged and washed two times. The washed pellet, which contained bacteria and adherent biotinylated endothelial membrane proteins, was dissolved in 2% SDS in 10 (19) . The membrane proteins were blotted to polyvinylidene difluoride (PVDF; Millipore Corp., Bedford, MA) using a TransBlot Cell (Bio-Rad Laboratories) (20) and the excess binding sites blocked with 10% milk (Carnation Co., Los Angeles, CA) in 10 mM Tris, pH 7.4, 0.9% NaCI for 2 h at 370C. The biotinylated membrane proteins that bound to S. aureus were identified with a streptavidin-alkaline phosphatase conjugate (Bethesda Research Laboratories, Life Technologies, Inc., Gaithersburg, MD) and the color developed with the chromogen 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt and nitroblue tetrazolium chloride (BRL) .
Isolation of the endothelial cell membrane protein which binds S. aureus. In the isolation procedure, 2-iminobiotin-NHS (50 mM; Pierce Chemical Co.) which has a pH dependent affinity for streptavidin, was used to label endothelial cell membranes (21, 22) . The solubilized iminobiotinylated membrane proteins were incubated with staphylococci for 2 h on ice as described for biotin-NHS. The suspension was centrifuged and the pellet containing S. aureus and the endothelial cell membrane protein was solubilized in either 4% Triton X-100, 50 mM borate buffer, pH 8 containing I mM PMSF, 10 mM benzamidine, I M NaCl and I mM EDTA or a 2% SDS buffer overnight. The material was then centrifuged at 10,000 g for 20 min and the supernatant collected. The pH of the supernatant was raised to 10 and then added to a 2-ml streptavidin-agarose column (Pierce). The column was washed with 10 column volumes of 50 mM sodium borate, pH 10 containing I M NaCl, 0.1 % Triton X-100 and I mM PMSF to remove any contaminating bacterial material. The bound iminobiotin-labeled material was then eluted with 50 mM ammonium acetate, pH 4, containing I M NaCl, 0.1% Triton and I mM PMSF.
Characterization ofthe endothelial cell membrane component. (23) . Control dilutions of purified fibronectin (10 ug/ml) and BSA (7.5 ug/ml) were applied. After 0.5 h, the nitrocellulose was removed from the apparatus and remaining sites blocked with 2% milk. The antibodies (1:1,000 dilution) were then added for 1.5 h. The blot was washed and probed with anti-rabbit, alkaline phosphatase-conjugated antibody (BRL) which was developed using a chromogenic substrate (BRL).
Preparation of endothelial cell conditioned, complete serum-free medium and complexes. To determine if the protein that binds S. aureus was released into the media, endothelial cell conditioned, serum free media was prepared as previously described (24) . 4-6 d after the umbilical vein endothelial cells were split, the proliferating cells were washed twice with M 199, 15 mM Hepes. The cells were then incubated in M 199 containing 1.6 mM glutamine, 15 mM Hepes, 5 pug of the partially purified growth factor, 100 U/ml penicillin, and 50 pg/mI streptomycin (complete serum-free medium) for 20 h at 370C.
Complexes were isolated from the conditioned serum free media as described (24) . The medium was removed and centrifuged for 10 min at 500 g to remove cells, for 20 min at 25,000 g to remove cell debris, and for 3 h at 150,000 g to precipitate the complexes. The pelleted complexes were resuspended in 10 mM sodium borate, pH 7 containing 1% Triton X-100, 10 mM benzamidine, 1 mM EDTA, 1 mM iodoacetamide, and 1 mM PMSF. The complexes were biotinylated and reacted with staphylococci as previously described. The serum free medium, following collection of the complexes was precipitated with 90% ammonium sulfate, the precipitate dissolved in solubilization buffer, biotinylated and reacted with staphylococci.
Preparation ofendothelial cell extracellular matrix. Endothelial cell extracellular matrix (ECM) was prepared as described previously (25, 26) . After removal of medium, cell monolayers were washed twice with 15 mM Hepes buffer, pH 7.6, at 370C. Cells were removed with I mM EGTA in Hepes buffer and ECM isolated with 0.5% Triton X-100 and 0.02 M NH40H. The plates were then washed three times with H20 to remove cell debris. ECM proteoglycans were then extracted under dissociative conditions with 4 M guanidine HCO buffer, pH 6.3, containing 2.0% Triton X-100, 0.1 M EDTA, 0.05 M sodium acetate and 2 mM iodoacetamide at 4°C for 48 h. The extraction was clear and centrifugation at 30,000 g for 1/2 h at 4°C did not produce a pellet. This extract was then biotin-labeled and reacted with bacteria.
Binding assay with the purified endothelial cell membrane protein
Binding of staphylococci to the purified protein was determined using a modification of the method of Froman et al. (27) . Removable microtiter wells (Immulon 2 Removawell strips, Dynatech Microtiter System, Chantilly, VA) were coated with the purified protein (300 pI) for 18 h at 4°C. The remaining liquid was aspirated off and the wells were then incubated for I h at 37°C with 10% milk in 10 
Results
Staphylococcal infection assay. Adherence of the Wb strain to the endothelial cell monolayer was both time and dose dependent. Saturation was demonstrable with an initial bacterial inoculum of 106 CFU/ml (Fig. 2) . Binding was rapid and appeared virtually complete by 5 min.
Identification of an endothelial cell membrane component that binds S. aureus. The biotin-NHS labeled, solubilized endothelial cell membranes were incubated with S. aureus and the complexes isolated by centrifugation. After detergent solubilization, the complexes were resolved by SDS-PAGE and blotted onto PVDF. A major 50-kD band was identified on the PVDF using alkaline phosphatase conjugated streptavidin (Fig. 3 a) . The solubilized staphylococci alone did not react with the streptavidin (not shown). The 50-kD component was also identified with two other adherent staphylococcal strains (not shown). Purification and characterization of the endothelial cell binding protein. An endothelial cell membrane binding protein was purified by iminobiotin-streptavidin affinity chromatography. Approximately 5 pg of purified protein was isolated from 1.6 X 107 cells. The component was similar in molecular weight to the 50-kD band identified using biotin-NHS labeled membranes (Fig. 3 b) . (Fig. 4) Binding of '25I-labeled endothelial cells to the purified membrane protein was investigated to determine ifthe protein had bivalent properties. Endothelial cell adherence was not increased above controls.
Competition assay. The effect of the partially purified membrane protein on staphylococcal adherence to human endothelial cells was evaluated. Preincubation of S. aureus for 1/2 h with the protein significantly decreased (P < 0.001, t test) adherence to the endothelial cells when compared with M 199 and ammonium acetate buffer controls (Table II) . Adherence was not diminished by preincubation of bacteria with physiologic concentrations of human fibrinogen (2.5 mg/ml) or serum albumin (35 mg/ml). The number of bacteria/endothelial cell was 18.1±5.3 for fibrinogen, 23.8±9.6 for human serum albumin versus 18.5±7.2 for elution buffer (mean±SD of four separate studies).
Discussion
Staphylococcal bacteremia is often complicated by endocarditis or metastatic suppurative collections (1-4) . The frequency with which these complications occur is greater with S. aureus than with most other bacterial pathogens. While the basis for this virulence is incompletely understood, it appears in part to result from the organisms ability to colonize endovascular surfaces and to elaborate proteolytic toxins, which facilitate bacterial migration to adjoining tissues. A classic example ofthis process is acute infective endocarditis where pre- viously normal valves are colonized and subsequently destroyed (3, 9) . We, and others, have demonstrated that S. aureus adhere more avidly to human endothelial cells in tissue culture and to endovascular tissue than other bacterial species (10) (11) (12) (13) (14) (15) . Investigators have speculated that this bacterial tropism may be the result of specific adhesin-receptor interactions (10) . The present study supports this hypothesis, since staphylococcal binding to the cultured human endothelial cells was saturable in both a dose and time dependent fashion (Fig. 2) .
While specific eucaryotic cell surface receptors for S. aureus have not been previously isolated, cellular receptors for other bacteria have been identified and purified. A glycolipid found on the surface of uroepithelial cells mediates E. coli attachment (28) and may contribute to the pathogenesis of urinary tract infections. The glycoprotein fibronectin coats buccal epithelial cells and thereby mediates group A streptococcal adherence (29) . Sanford et al. (30, 31) have investigated the basis for increased staphylococcal adherence to viral infected cells. They have identified several membrane polypeptides present on virus infected and uninfected Madin-Darby canine kidney cells which bind S. aureus surface proteins.
They speculate that these components may play a role in the increased binding of S. aureus to influenza infected cells.
We have developed and utilized a novel approach for the isolation and purification of host tissue receptors or bacterial ligands. This technique relies on the pH dependent affinity of iminobiotin-NHS for streptavidin (21, 22 The endothelium is a dynamic cell type that plays an important role in vascular function. Many of these functions are mediated by a variety of surface molecules that have been identified on the endothelial cell. These include receptors that determine sites for cell binding and transit (ICAM-I, LFA-3), as well as binding sites for a variety of macromolecules (32) (33) (34) . Most of the previously identified membrane proteins and glycoproteins are larger than 50 kD. The purification of the S. aureus binding protein was performed at 4°C in the presence of protease inhibitors in order to reduce the likelihood that the isolated component was a degradation fragment of a larger molecule. Matrix glycoproteins such as fibronectin, laminin, and collagen have been shown to bind S. aureus (5-7). Fibronectin, in particular, has been identified as an important mediator of staphylococcal adhesion in the presence of tissue injury. Its presence in the nonbacterial thrombus encountered on traumatized valvular surfaces in subacute infective endocarditis results in increased bacterial adhesion (6). Fibronectin does not appear to have a major role in the present binding interaction since it is not expressed on the luminal surfaces of endothelial cells. In addition, the purified protein did not react with antifibronectin antisera. It is likely that S. aureus colonization oftissue surfaces is a complex process and, as with other bacterial-tissue interactions, involves more than a single adhesinreceptor interaction.
Our investigation has shown that S. aureus binding to endothelium is saturable with both dose and time supporting the specificity of binding. The 
